epilepsy

News

EpiWatch app detects major seizures with few false alarms

An Apple Watch patient monitoring app can help people with epilepsy reduce the risk of sudden death, with high sensitivity and a low false alarm rate.

R&D

Why UCB bet a billion dollars on cell therapy for epilepsy

UCB's chief science officer spoke to pharmaphorum about why Neurona's in-development cell therapy could be a game changer for epilepsy treatment.

News

Angelini CEO Sergio Marullo di Condojanni

Angelini seeks US beachhead with $4.1bn Catalyst buy

Angelini has agreed to buy Catalyst Pharma for up to $4.1bn, its first acquisition since 2021, which would mark its entry into the US market.

News

UCB cuts $1.15bn deal to buy epilepsy biotech Neurona

UCB has dipped its toe into the M&A waters once again with an agreement to buy US biotech Neurona and its cell therapy for a common form of epilepsy.

News

Marcio Souza, Praxis' president and chief executive

Praxis soars on rare childhood epilepsy trial data

Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.

News

Wearable monitor via smartphone and ear device

Wearable alert system for epileptics set for European launch

An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.

EpiWatch app detects major seizures with few false alarms

Why UCB bet a billion dollars on cell therapy for epilepsy

Angelini seeks US beachhead with $4.1bn Catalyst buy

UCB cuts $1.15bn deal to buy epilepsy biotech Neurona

Praxis soars on rare childhood epilepsy trial data

Wearable alert system for epileptics set for European launch

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

epilepsy

Editor's Picks